HMGB1: A Promising Therapeutic Target for Prostate Cancer

1Department of Biomedical Sciences, College of Medicine, University of Illinois, 1601 Parkview Avenue, Rockford, IL 61107, USA2Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA

H. Yang, M. Ochani, J. Li et al., “Reversing established sepsis with antagonists of endogenous high-mobility group box 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 296–301, 2004.View at Publisher · View at Google Scholar · View at Scopus